| 000 | 01354 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517105139.0 | ||
| 264 | 0 | _c20170724 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1471-4973 | ||
| 024 | 7 |
_a10.1016/j.coph.2016.06.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHatfield, Stephen M | |
| 245 | 0 | 0 |
_aA2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. _h[electronic resource] |
| 260 |
_bCurrent opinion in pharmacology _c08 2016 |
||
| 300 |
_a90-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenosine _xmetabolism |
| 650 | 0 | 4 |
_aAdenosine A2 Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _ximmunology |
| 650 | 0 | 4 |
_aImmune Tolerance _ximmunology |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSignal Transduction _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTumor Microenvironment _ximmunology |
| 700 | 1 | _aSitkovsky, Michail | |
| 773 | 0 |
_tCurrent opinion in pharmacology _gvol. 29 _gp. 90-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coph.2016.06.009 _zAvailable from publisher's website |
| 999 |
_c26238380 _d26238380 |
||